Vladimir Todorović

dr sci med Vladimir Todorović

redovni profesor | Medicinski fakultet | dopunski rad | honorarno

Prof. dr Vladimir Todorovic rodjen je 1964. godine u Subotici gde je završio osnovno i srednje obrazovanje. Medicinski fakultet završava 1990. godine u Novom Sadu. Specijalizaciju Interne medicine polaže 1996. godine u Kliničkom Centru Srbije i Univerzitetu u Beogradu, a subspecijalizaciju iz Onkologije 1998. na Institutu za onkologiju i radiologiju kao i Univerzitetu u Beogradu. Zvanje Magistra medicinskih nauka dobija 1997., a Doktorsku disertaciju brani 2000. godine na Beogradskom Univerzitetu. Sledeće godine je biran za Asistenta za predmet Onkologija...

Nastava

Jedinica Program Tip Sem. Predmet P x GP V x GV L x GL
MEDMEDICINAOsnovne3OSNOVI KLINIČKE PRAKSE II.16 x 10 x 00 x 0
MEDMEDICINAOsnovne2OSNOVI KLINIČKE PRAKSE I.16 x 10 x 00 x 0
MEDMEDICINAOsnovne5VJEŠTINE KOMUNIKACIJE U MEDICINI.5 x 10 x 00 x 0
MEDMEDICINAOsnovne11ONKOLOGIJA2 x 12 x 20 x 0

Izabrane publikacije

Godina Kategorija Autori Naslov Izvor
2024SCI, SCIE, SSCI, A&HCI
Janja Raonić, Maša Ždralević, Ljiljana Vučković, Milena Šunjević, Vladimir Todorović, Filip Vukmirović, Flaviana Marzano, Apollonia Tullo, Sergio Giannattasio, Miodrag RadunovićmiR-29a expression negatively correlates with Bcl-2 levels in colorectal cancer and is correlated with better prognosisPathology - Research and Practice
2023SCI, SCIE, SSCI, A&HCI
Ždralević M, Raonić J, Popovic N, Vučković L, Rovčanin Dragović I, Vukčević B, Todorović V, Vukmirović F, Marzano F, Tullo A, Guaragnella N, Giannattasio S, Radunović MThe role of miRNA in colorectal cancer diagnosis: A pilot studyOncology Letters
2022SCI, SCIE, SSCI, A&HCI
Dosanjh M, Ristova M, Gershan V, Georgieva P, Balin Kovacevic M, Bregu L, Coralic I, Djurovic T, Dosieva D, Foka Y, Fröbe A, Hatziioannou K, Hourdakis CJ, Kabashi Y, Kalev D, Kurtishi I, Litov L, Mezelxhiu B, Nestoroska Madjunarova S, Nikolova G, Skrk D, Smajlbegovic V, Smichkoska S, Stojkovski I, Strojan P, Tecic Z, Tešanović D, Todorovic V, Valerianova Z. Availability of technology for managing cancer patients in the Southeast European (SEE) regionClin Transl Radiat Oncol
2021SCI, SCIE, SSCI, A&HCI
Kandolf-Sekulovic L, Peris K, Stratigos A, Hauschild A, Forsea AM, Lebbe C, Lallas A, Grob JJ, Harwood C, Gogas H, Rutkowski P, Olah J, Kelleners-Smeets NWJ, Paoli J, Dummer R, Moreno-Ramirez D, Bastholt L, Putnik K, Karls R, Hoeller C, Vandersleyen V, Vieira R, Arenberger P, Bylaite-Buckinskiene M, Ocvirk J, Situm M, Weinlich G, Banjin M, Todorovic V, Ymeri A, Zhukavets A, Garbe CWhich medical disciplines diagnose and treat melanoma in Europe in 2019? A survey of experts from melanoma centres in 27 European countriesEur Acad Dermatol Venereol
2020SCI, SCIE, SSCI, A&HCI
Feng Du, Wenmiao Wang, Yongsheng Wang, Ming Li, Anjie Zhu, Jiayu Wang, Ruigang Cai, Fei Ma, Ying Fan, Qing Li, Pin Zhang, Vladimir Todorovic, Peng Yuan & Binghe XuCarboplatin plus taxanes are non-inferior to epirubicin plus cyclophosphamide followed by taxanes as adjuvant chemotherapy for early triple-negative breast cancerBreast Cancer Res Treat
2020SCI, SCIE, SSCI, A&HCI
Belkacemi Y, Grellier N, Ghith S, Debbi K, Coraggio G, Bounedjar A, Samlali R, Tsoutsou PG, Ozsahin M, Chauvet MP, Turkan S, Boussen H, Kuten A, Tesanovic D, Errihani H, Benna F, Bouzid K, Idbaih A, Mokhtari K, Popovic L, Spano JP, Lotz JP, Cherif A, To H, Kovcin V, Arsovski O, Beslija S, Dzodic R, Markovic I, Vasovic S, Stamatovic L, Radosavljevic D, Radulovic S, Vrbanec D, Sahraoui S, Vasev N, Stojkovski I, Risteski M, Freixa SV, Krengli M, Radosevic N, Mustacchi G, Filipovic M, Kerrou K, Taghian AG, Todorovic V, Geara F, Gligorov J. A review of the international early recommendations for departments organization and cancer management priorities during the global COVID-19 pandemic: applicability in low- and middle-income countries. Eur J Cancer
2020SCI, SCIE, SSCI, A&HCI
Nicholas Pavlidis , Vladimir Todorovic, Elie Rassy, Hussein Khaled, Fedro Peccatori, Alex Eniu, Matti Aapro & Joseph GligorovThe management of patients with cancer of unknown primary in middle-income countries: an ESO-AROME surveyFuture Oncology
2019SCI, SCIE, SSCI, A&HCI
EDUARD VRDOLJAK, GYORGY BODOKY, JACEK JASSEM, RAZVAN POPESCU, ROBERT PIRKER, TANJA ČUFER, SEMIR BEŠLIJA, ALEXANDRU ENIU, VLADIMIR TODOROVIĆ, KATERINA KOPEcKOVÁ, GALIA KURTEVA, ZORICA TOMAŠEVIĆ, AGIM SALLAKU, SNEZHANA SMICHKOSKA, ŽARKO BAJIĆ, BRANIMIR SIKICExpenditures on Oncology Drugs and Cancer Mortality-to- Incidence Ratio in Central and Eastern EuropeOncologist
2019SCI, SCIE, SSCI, A&HCI
Todorovic V, Aapro M, Pavlidis N, Arsovski O, Belkacemi Y, Babovic N, Bidard FC, Bourhafour M, Beslija S, Boussen H, Cetnikovic B, Ceric T, Cicmil N, Crnogorac N, Cuedari E, De Laurentis M, Dragovich T, Durutovic I, Dzamic Z, Dzodic R, Eri Z, Geara F, Khalil A, Kerrou K, Knezevic Usaj S, Kovcin V, Koroveshi D, Kristo Pema A, Kuten A, Lakicevic J, Lukovac N, Markovic I, Markovic M, Mijalkovic N, Miladinova D, Milasevic N, Mustachi G, Ognjenovic D, Pantelic A, Popovic L, Radosavljevic D, Radosevic N, Radulovic S, Ristevski M, Rosic I, Secen N, Sorat M, Stamatovic L, Stefanovski P, Stojkovski I, Tesanovic D, Tomasevic Z, Tomasevic Z, Tsoutsou P, Turkan S, Vasev N, Vasovic S, Vicko F, Vrbanec D, Vukmirovic F, Vrdoljak E, Zaric B, Zambrovski JJ, Cavalli F, Gligorov J.AROME-ESO Oncology Consensus Conference: access to cancer care innovations in countries with limited resources. Association of Radiotherapy and Oncology of the Mediterranean Area (AROME-Paris) and European School of Oncology (ESO - Milan).J BUON
2018SCI, SCIE, SSCI, A&HCI
Kandolf Sekulovic L, Guo J, Agarwala S, Hauschild A, McArthur G, Cinat G, Wainstein A, Caglevic C, Lorigan P, Gogas H, Alvarez M, Duncombe R, Lebbe C, Peris K, Rutkowski P, Stratigos A, Forsea AM, De La Cruz Merino L, Kukushkina M, Dummer R, Hoeller C, Gorry C, Bastholt L, Herceg D, Neyns B, Vieira R, Arenberger P, Bylaite-Bucinskiene M, Babovic N, Banjin M, Putnik K, Todorovic V, Kirov K, Ocvirk J, Zhukavets A, Ymeri A, Stojkovski I, Garbe CAccess to innovative medicines for metastatic melanoma worldwide: Melanoma World Society and European Association of Dermato-oncology survey in 34 countriesEur J Cancer
2017SCI, SCIE, SSCI, A&HCI
Vladimir Todorovic, Nada Cicmil Saric, Jadranka Lakicevic, Milan SoratEvaluation of safety of bevacizumab as second-line treatment of patients with metastatic colorectal cancerJOURNAL OF BUON
2017SCI, SCIE, SSCI, A&HCI
Gligorov J, Richard S, Todorovic VNew anti-HER2 agents: from second-generation tyrosine kinases inhibitors to bifunctional antibodiesCurr Opin Oncol
2017SCI, SCIE, SSCI, A&HCI
Kandolf Sekulovic L, Peris K, Hauschild A, Stratigos A, Grob JJ, Nathan P, Dummer R, Forsea AM, Hoeller C, Gogas H, Demidov L, Lebbe C, Blank C, Olah J, Bastholt L, Herceg D, Neyns B, Vieira R, Hansson J, Rutkowski P, Krajsova I, Bylaite-Bucinskiene M, Zalaudek I, Maric-Brozic J, Babovic N, Banjin M, Putnik K, Weinlich G, Todorovic V, Kirov K, Ocvirk J, Zhukavets A, Kukushkina M, De La Cruz Merino L, Ymeri A, Risteski M, Garbe CMore than 5000 patients with metastatic melanoma in Europe per year do not have access to recommended first-line innovative treatmentsEur J Cancer
2016SCI, SCIE, SSCI, A&HCI
Vrdoljak E, Bodoky G, Jassem J, Popescu RA, Mardiak J, Pirker R, Čufer T, Bešlija S, Eniu A, Todorović V, Kubáčková K, Kurteva G, Tomašević Z, Sallaku A, Smichkoska S, Bajić Ž, Šikić BICancer Control in Central and Eastern Europe: Current Situation and Recommendations for ImprovementOncologist
2014SCI, SCIE, SSCI, A&HCI
Todorović, V.Prevention and management of stomatitis during treatment with EverolimusWulfenia
2014SCI, SCIE, SSCI, A&HCI
Todorović, V., Damjanović, S. & Lukovac Janjić, N. Targeted therapy in metastatic hereditary Paragangliomas Mitteilungen Klosterneuburg
2011SCI, SCIE, SSCI, A&HCI
Vrdoljak, E., Wojtukiewicz, MZ., Pienkowski, T., Bodoky, G., Berzinec, P., Finek, J., Todorović, V., Borojević, N., Croitoru, A. & South Eastern European Research Oncology GroupCancer epidemiology in Central and South Eastern European countriesCroatian Medical Journal

Obavjestenja iz nastave